Publications by authors named "Scott Karlan"

Claim this Profile
P
PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
Alice Y Ho, Stephen Shiao, Samantha A Kobald, Jonathan Chen, Dan G Duda, Scott Karlan

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 Years with ER+ Breast Cancer.
Alice P Chung, Catherine M Dang, Scott R Karlan, Farin F Amersi, Edward M Phillips

Ann Surg Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects.
Oukseub Lee, Latifa A Bazzi, Yanfei Xu, Erik Pearson, Minhua Wang, Scott Karlan

Biomed Pharmacother· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer.
Stephen L Shiao, Kenneth H Gouin, Nathan Ing, Alice Ho, Reva Basho, Scott Karlan

Cancer Cell· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double-Blind, Placebo-Controlled Phase II Trial.
Oukseub Lee, Melissa Pilewskie, Scott Karlan, Mary B Tull, Kelly Benante

Clin Pharmacol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies.
Freya Schnabel, Susan K Boolbol, Mark Gittleman, Tami Karni, Lorraine Tafra, Scott Karlan

Ann Surg Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.
Lei Zhang, Hua Xiao, Scott Karlan, Hui Zhou, Jenny Gross, Beth Karlan

PLoS One· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detection.
Michèl Schummer, Ann Green, J David Beatty, Beth Y Karlan, Scott Karlan

PLoS One· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased use of MRI for breast cancer surveillance and staging is not associated with increased rate of mastectomy.
Catherine M Dang, Karen Zaghiyan, Scott R Karlan, Edward H Phillips

Am Surg· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative FDG-PET for axillary metastases in patients with breast cancer.
Alice Chung, Doug Liou, Scott Karlan, Alan Waxman, Kayo Fujimoto

Arch Surg· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo cytometry: a spectrum of possibilities.
Alice Chung, Scott Karlan, Erik Lindsley, Sebastian Wachsmann-Hogiu, Daniel L Farkas

Cytometry A· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis